5 institutions reported holding $4.7M of BIOCRYST PHARMACEUTICALS INC (BCRX) in SEC 13F filings for 2026-06-30. Largest institutional holders: Assenagon Asset Management S.A. ($3.5M), Hennion & Walsh Asset Management, Inc. ($1.1M), Versant Capital Management, Inc ($20,030), GAMMA Investing LLC ($12,290), Arlington Trust Co LLC ($1,500). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | $3.5M | 353,044 | Added |
| 2 | Hennion & Walsh Asset Management, Inc. | $1.1M | 112,893 | Trimmed |
| 3 | Versant Capital Management, Inc | $20,030 | 2,003 | Added |
| 4 | GAMMA Investing LLC | $12,290 | 1,229 | Added |
| 5 | Arlington Trust Co LLC | $1,500 | 150 | New |
Source: SEC Form 13F filings · as of 2026-06-30